Epidemiology and burden of malaria in pregnancy

M Desai, FO Ter Kuile, F Nosten… - The Lancet infectious …, 2007 - thelancet.com
We reviewed evidence of the clinical implications and burden of malaria in pregnancy. Most
studies come from sub-Saharan Africa, where approximately 25 million pregnant women are …

Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study

…, J Williams, K Bojang, F Njie, M Desai… - The Journal of …, 2015 - academic.oup.com
Plasmodium falciparum parasites that are resistant to artemisinins have been detected in
Southeast Asia. Resistance is associated with several polymorphisms in the parasite's K13-…

Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem

SJ Rogerson, M Desai, A Mayor, E Sicuri… - The Lancet infectious …, 2018 - thelancet.com
Over the past 10 years, knowledge of the burden, economic costs, and consequences of
malaria in pregnancy has improved, and the prevalence of malaria caused by Plasmodium …

Profile: the KEMRI/CDC health and demographic surveillance system—Western Kenya

…, M Ombok, K Lindblade, M Desai… - International journal …, 2012 - academic.oup.com
The KEMRI/Centers for Disease Control and Prevention (CDC) Health and Demographic
Surveillance System (HDSS) is located in Rarieda, Siaya and Gem Districts (Siaya County), …

[HTML][HTML] Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment …

…, S Borrmann, F Checchi, M Desai… - The American journal …, 2014 - ncbi.nlm.nih.gov
Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the
artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum …

Evaluating an intervention to improve communication between oncology clinicians and patients with life-limiting cancer: a cluster randomized clinical trial of the …

…, SP Miranda, M Palmor, J Lakin, M Desai… - JAMA …, 2019 - jamanetwork.com
Importance Earlier clinician-patient conversations about patients’ values, goals, and preferences
in serious illness (ie,serious illness conversations) are associated with better outcomes …

Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin–piperaquine versus intermittent preventive treatment with sulfadoxine …

M Desai, J Gutman, A L'lanziva, K Otieno, E Juma… - The Lancet, 2015 - thelancet.com
Background Every year, more than 32 million pregnancies in sub-Saharan Africa are at risk
of malaria infection and its adverse consequences. The effectiveness of the intermittent …

Perspectives of men on antenatal and delivery care service utilisation in rural western Kenya: a qualitative study

TK Kwambai, S Dellicour, M Desai, CA Ameh… - BMC pregnancy and …, 2013 - Springer
Background Poor utilisation of facility-based antenatal and delivery care services in Kenya
hampers reduction of maternal mortality. Studies suggest that the participation of men in …

Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low …

M Desai, J Gutman, SM Taylor… - Clinical Infectious …, 2016 - academic.oup.com
Background. Owing to increasing sulfadoxine-pyrimethamine (SP) resistance in sub-Saharan
Africa, monitoring the effectiveness of intermittent preventive therapy in pregnancy (IPTp) …

Prevention of malaria in pregnancy

M Desai, J Hill, S Fernandes, P Walker… - The Lancet infectious …, 2018 - thelancet.com
Malaria remains one of the most preventable causes of adverse birth outcomes. Intermittent
preventive treatment in pregnancy (IPTp) with sulfadoxine–pyrimethamine is used to prevent …